Icon Launches New Patient Engagement Platform to Support Improved Patient Experience and Enrollment in Clinical Trials

Mati Therapeutics Phase II Nepafenac Evolute Clinical Trial Results Show Significant Post-Operative Pain Reduction in Cataract Surgery Patients

Ally Bridge Group leads USD65m investment in Pulmonx

GenSight Biologics Touts Positive Data Safety Monitoring Board Review and Continuation of PIONEER Phase I/II Clinical Trial of GS030 Combining Gene Therapy and Optogenetics for the Treatment of Retinitis Pigmentosa

Impulse Dynamics treats first heart failure patient with Optimizer Smart System at Ohio State University Wexner Medical Center

Optina passes US FDA's breakthrough device designation to expedite development of retinal imaging platform for Alzheimer's disease detection

CryoConcepts awarded US FDA market clearance for two cryosurgical devices

Rapid Medical wins US FDA approval for novel temporary aneurysm embolization assist device, Comaneci

Recros Medica announces US FDA De Novo submission for Nuvellus Focal Contouring System

Natera Inc passes US FDA breakthrough device designation for use of the Signatera Test in pharmaceutical trials

Vivera Pharmaceuticals Names McColgan Chief Medical Officer

Allergan' board sets quarterly dividend payment date of 14 June 2019

Caris Life awarded US FDA's breakthrough device designation for MI Transcriptome companion diagnostic test to detect gene fusions across all solid tumor

ISAPS announces the US FDA's allowance of textured surface breast implant sales

DarioHealth collaborates with American Diabetes Association